Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed with different criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease indicate shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. Only one locus differed in its association by diagnostic criteria, otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or Rotterdam criteria across common variants at 13 loci. 5 Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women, with a complex pattern of inheritance 1-5 . Two different diagnostic criteria based on expert opinion have been utilized: The National Institutes of Health (NIH) criteria require hyperandrogenism (HA) and ovulatory dysfunction (OD) 6 while the Rotterdam criteria include the presence of polycystic ovarian morphology (PCOM) and requires at least two of three traits to be present, resulting in four phenotypes (Supplementary Figure 1) 6, 7 . PCOS by NIH criteria has a prevalence of ~7% in reproductive age women worldwide 8 ; the use of the broader Rotterdam criteria increases this to 15-20% across different populations 9-11 .
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Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive aged women, with a complex pattern of inheritance [1] [2] [3] [4] [5] . Two different diagnostic criteria based on expert opinion have been utilized: The National Institutes of Health (NIH) criteria require hyperandrogenism (HA) and ovulatory dysfunction (OD) 6 while the Rotterdam criteria include the presence of polycystic ovarian morphology (PCOM) and requires at least two of three traits to be present, resulting in four phenotypes (Supplementary Figure 1) 6, 7 . PCOS by NIH criteria has a prevalence of ~7% in reproductive age women worldwide 8 ; the use of the broader Rotterdam criteria increases this to 15-20% across different populations [9] [10] [11] .
PCOS is commonly associated with insulin resistance, pancreatic beta cell dysfunction, obesity and type 2 diabetes (T2D). These metabolic abnormalities are most pronounced in women with the NIH phenotype 12 . In addition, the odds for moderate or severe depression and anxiety disorders are higher in women with PCOS 13 . However, the mechanisms behind the association between the reproductive, metabolic and psychiatric features of the syndrome remain largely unknown.
Genome-wide association studies (GWAS) in women of Han Chinese and European ancestry have reproducibly identified 16 loci [14] [15] [16] [17] . The observed susceptibility loci in PCOS appeared to be shared between NIH criteria and self-reported diagnosis 17 , which is particularly intriguing. Genetic analyses of causality (by Mendelian Randomization analysis) among women of European ancestry with self-reported PCOS suggested that body mass index (BMI), insulin resistance, age at menopause and sex hormone binding globulin contribute to disease pathogenesis 17 .
We performed the largest GWAS meta-analysis of PCOS to date, in 10,074 cases and 103,164 controls of European ancestry diagnosed with PCOS according to the NIH (2,540 cases and 15,020 controls) or Rotterdam criteria (2,669 cases and 17,035 controls), or by self-reported diagnosis (5, 184 cases and 82,759 controls) ( Table 1 and Supplementary Table 1 ). We investigated whether there were differences in the genetic architecture across the diagnostic criteria, and whether there were distinctive susceptibility loci associated with the cardinal features of PCOS; HA, OD and PCOM.
Further, we explored the genetic architecture with a range of phenotypes related to the biology of PCOS, including male-pattern balding [18] [19] [20] [21] .
We identified 14 genetic susceptibility loci associated with PCOS, adjusting for age, at the genome-wide significance level (P < 5.0 x 10 -8 ) bringing the total number of PCOS associated loci to nineteen (Table 2, Figure 1 ). Three of these loci were novel associations (near PLGRKT, ZBTB16 and MAPRE1, respectively; shown in bold in Table 2 ). Six of the 11 reported associations were previously observed in Han Chinese PCOS women 14, 15 . Eight loci have been reported in European PCOS cohorts 16, 17 . Obesity is commonly associated with PCOS and in most of the cohorts cases were heavier than controls ( Table 1) . However, adjusting for both age and BMI did not identify any novel loci; and the 14 loci remained genome-wide significant. Only one SNP near GATA4/NEIL2 showed significant evidence of heterogeneity across the different diagnostic groups (Figure 2 ; Table 2 , rs804279, Het P=2.9x10 -4 ). For this SNP, the largest effect was seen in NIH cases and the smallest in self-reported cases. Credible set analysis, which prioritises variants in a given locus with regards to being potentially causal, was able to reduce the plausible interval for the causal variant(s) at many loci ( Supplementary Table 2 ). Of note, 95% of the signal at the THADA locus came from two SNPs. Examination of previously published genomewide significant loci from Han Chinese PCOS 14, 15 demonstrated that index variants from the THADA, FSHR, C9orf3, YAP1 and RAB5B loci were significantly associated with PCOS after Bonferroni correction for multiple testing in our European ancestry subjects ( Supplementary Table 3 ).
We assessed the association of the PCOS susceptibility variants identified in the GWAS meta-analysis with the PCOS related traits: HA, OD, PCOM, testosterone, FSH and LH levels, and ovarian volume in PCOS cases ( Table 3 , Supplementary   Figure 2 and Supplementary Table 4 ). We found four variants associated with HA, eight variants associated with PCOM and nine variants associated with OD. Of the eight loci associated with PCOM, seven were also associated with OD. Three of the four loci associated with HA were also associated with OD and PCOM. Two additional loci were associated with OD alone, one of which was the locus near FSHB ( Supplementary Table 4 ). This locus was also associated with LH and FSH levels.
There was a single PCOS locus near IRF1/RAD50 associated with testosterone levels (Supplementary Table 4 ). We repeated this analysis with susceptibility variants reported previously in Han Chinese PCOS cohorts 14, 15 . In this analysis, there was one association with HA (near DENND1A), three with PCOM and three with OD ( Supplementary Table 3 ). A limitation of these analyses is the variable sample size across the phenotypes analysed. Additionally, the known referral bias for the more severely affected NIH phenotype (patients having both OD and HA) may result in more PCOS diagnoses than the other criteria 35 , and may have contributed to the number of associations between the identified PCOS risk loci and these phenotypes.
In the analyses looking at the weighted genetic risk score in the Rotterdam cohort, we observed an increase in the risk for PCOS ( Supplementary Figure 3 ). Compared to individuals in the third quintile (reference group), individuals in the top 5th quintile of risk score have an OR of 2.78 (95% CI) for PCOS based on NIH criteria and an OR of 3.39 (95% CI) for Rotterdam criteria based PCOS. Of the associations, only the effect estimate for the Rotterdam criteria was significant, possibly due to the smaller size available with cases diagnosed according to the NIH criteria. When looking at the area under the ROC curves at SNPs with different P-value thresholds, we found a maximum AUC of 0.54 using SNPs with a P-value < 5x10 -6 for both diagnostic criteria.
While this is significantly better than chance, it is unlikely that a risk score generated from the variants discovered to date would represent a clinically relevant tool.
LD score regression analysis revealed genetic correlations with childhood obesity, fasting insulin, T2D, HDL, menarche timing, triglyceride levels, cardiovascular diseases and depression ( Table 4 ) suggesting that there is shared genetic architecture and biology between these phenotypes and PCOS. There were no genetic correlations with menopause timing or male pattern balding. Mendelian randomization suggested that there was a causal role for BMI, fasting insulin and depression pathways ( Table 5) . Interestingly, while there was no genetic correlation detected for male pattern balding or menopause timing with PCOS, the Mendelian randomization analysis was significant. The importance of BMI pathways on reproductive phenotypes was further demonstrated by the attenuation of significance of Mendelian randomization analysis for age-at-menarche when BMI-associated variants were excluded from the analysis.
We found 14 independent loci significantly associated with the risk for PCOS, including three novel loci. The 11 previously reported loci implicated neuroendocrine and metabolic pathways that may contribute to PCOS (Supplementary Note 1.1).
Two of the novel loci contain potential endocrine related candidate genes. The locus harbouring rs10739076 contains several interesting candidate genes; PLGRKT, a plasminogen receptor and several genes in the insulin superfamily; INSL6, INSL4 and RLN1, RLN2 which are endocrine hormones secreted by the ovary and testis and are suspected to impact follicle growth and ovulation 22 . ZBTB16 (also known as PLZF) has been marked as an androgen-responsive gene with anti-proliferative activity in prostate cancer cells 23 . PLZF activates GATA4 gene transcription and mediates cardiac hypertrophic signalling from the angiotensin II receptor 2 24 . Furthermore, PLZF is upregulated during adipocyte differentiation in vitro 25 and is involved in control of early stages of spermatogenesis 26 and endometrial stromal cell decidualization 27 .
The third novel locus harbours a metabolic candidate gene; MAPRE1 (interacts with the low-density lipoprotein receptor related protein 1 (LRP1), which controls adipogenesis 28 and may additionally mediate ovarian angiogenesis and follicle development 29 (Supplementary Note 1.2) . Thus, all the new loci contain genes plausibly linked to both the metabolic and reproductive features of PCOS.
We found that there was no significant difference in the association with case status for the majority of the PCOS-susceptibility loci by diagnostic criteria. However, due to lack of power, it was not possible to compare each of the four PCOS phenotypes (Supplementary Figure 1 ). Cohorts containing both NIH and non-NIH Rotterdam phenotypes were compared to cohorts containing only the NIH phenotype. Although the inclusion of NIH phenotypes in the Rotterdam criteria cohorts could have masked differences in genetic architecture between the NIH and non-NIH Rotterdam phenotypes, the non-NIH Rotterdam subjects made up 53% of the cohorts. It is of considerable interest that the cohort of research participants from the personal genetics company 23andMe, Inc., identified by self-report, had similar risks to the other cohorts where the diagnosis was clinically confirmed. Our findings suggest that the genetic architecture of these PCOS definitions does not differ for common susceptibility variants. If these results are confirmed when the Rotterdam diagnostic subsets are compared ( Supplementary Figure 1) , data should be combined in future efforts to map the genetic architecture and molecular pathways underlying PCOS.
Only one locus, GATA4/NEIL2 (rs804279), was significantly different across diagnostic criteria: most strongly associated in NIH compared to the Rotterdam phenotype and self-reported cases. Deletion of GATA4 results in abnormal responses to exogenous gonadotropins and impaired fertility in mice 30 . The locus also encompasses the promoter region of FDFT1, the first enzyme in the cholesterol biosynthesis pathway 31 , which is the substrate for testosterone synthesis, and is associated with non-alcoholic fatty liver disease 32 . The major difference between the NIH phenotype and the additional Rotterdam phenotypes is metabolic risk; the NIH phenotype is associated with more severe insulin resistance 33 The significant association of PCOS GWAS meta-analysis susceptibility variants with the cardinal PCOS related traits OD, HA and PCOM further strengthened the hypothesis that specific variants may confer risk for PCOS through distinct mechanisms. Three variants at the C9orf3, DENND1A, and RAB5B were associated with all PCOS related traits. The findings were consistent with the Han Chinese DENND1A variant association with HA, as suggested previously 34 . Thus, these loci, along with GATA4/NEIL2 (as discussed above) may help identify pathways that link specific PCOS related traits with greater metabolic risk. In contrast, the variants at the ERBB4, YAP1, and ZBTB16 loci were strongly associated with OD and PCOM, and therefore, might be more important for links to menstrual cycle regularity and fertility.
In addition, the FSHB variant was associated with the levels of FSH and LH 16, 17 , suggesting that it may act by affecting gonadotropin levels. This variant maps 2kb upstream from open chromatin (identified by DNase-Seq) and an enhancer (identified by peaks for both H3K27Ac and H3K4me1) in a lymphoblastoid cell line from ENCODE, indicating a potential role for a regulatory element ~25kb upstream from the FSHB promoter. Furthermore, the association between the IRF1/RAD50 variant and testosterone levels may indicate a regulatory role in testosterone production.
Of note, results of the follow-up analysis show a high level of shared biology between PCOS and a range of metabolic outcomes consistent with the previous findings 17 . In particular, there is genetic evidence for increased BMI as a risk factor for PCOS.
There is also genetic evidence that fasting insulin might be an independent risk factor, but there might also be pleiotropic effects across the variants given the results from different Mendelian randomization analyses. This study also confirmed a causal association with the pathways that underlie menopause 17 , suggesting that PCOS has shared aetiology with both classic metabolic and reproductive phenotypes.
Furthermore, there was an apparent effect of depression-associated variants on the likelihood of PCOS, suggesting a role for psychological factors on hormonally related diseases. However, the links between PCOS and depression might be complicated by pathways that are also related to BMI. In addition, male-pattern balding-associated variants showed strong effects on PCOS, suggesting that this might be a male manifestation of PCOS pathways, as has been previously suggested 18, 20, 21, 36 . This observation may reflect the biology of hair follicle sensitivity to androgens, seen in androgenetic alopecia, a well-recognised feature of HA and PCOS 37, 38 . The Mendelian randomization results for male-pattern balding and menopause are significant despite non-significant genetic correlation results, suggesting that the shared aetiology may be specific to only a few key pathways.
In conclusion, the genetic underpinnings of PCOS implicate neuroendocrine, metabolic and reproductive pathways in the pathogenesis of disease. Although specific phenotype stratified analyses are needed, genetic findings were consistent across the diagnostic criteria for all but one susceptibility locus, suggesting a common genetic architecture underlying the different phenotypes. There was genetic evidence for shared biologic pathways between PCOS and a number of metabolic disorders, menopause, depression and male-pattern balding, a putative male phenotype. Our findings demonstrate the extensive power of genetic and genomic approaches to elucidate the pathophysiology of PCOS. Specific OR's [95% CI, 5% CI] are indicated on the right. rs804279 in the GATA4/NEIL2 locus demonstrates significant heterogeneity (Het P =2.9x10 -4 ). The * indicates statistically significant association for PCOS and the variant in that specific stratum. 
ONLINE METHODS

Methods
Subjects
The meta-analysis included 10,074 cases and 103,164 controls from seven cohorts of European descent. For the analysis of PCOS related traits three additional cohorts, the Northern Finnish Birth Cohort (NFB66) 39 , Twins UK 40 HA was defined as hirsutism and quantified by the Ferriman-Gallwey (FG) score. The FG score assesses terminal hair growth in a male pattern in females, and a score above the upper limit of normal controls (>8) is considered hirsutism 42 .
Hyperandrogenemia was defined as testosterone, androstenedione or DHEAS greater than the 95% confidence limits in control subjects in the individual population.
OD was defined as cycle interval <21 or >35 days 43 . PCOM was defined as 12 or more follicles of 2-9 mm in at least one ovary or an ovarian volume >10 mL 7 . The quantitative PCOS traits included levels of total testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) and ovarian volume ( Supplementary   Table 1 ). An overview of the cohorts, diagnostic criteria and number of subjects included are summarized in Table 1 and Supplementary Table 1 . All studies were approved by the Institutional Review Board at the recruiting site and all subjects signed written, informed consent.
Data Collection and Quality Control
Each study provided summary results of genetic per-variant-estimates produced in either case-control or trait association analyses. The collected files underwent central quality control (QC) using the EasyQC pipeline 44 . Variants were excluded based on minor allele frequency (MAF) < 1%, imputation quality (R 2 ) < 0.3 or info < 0.4 for MACH and IMPUTE2 respectively 45, 46 .
Meta-analysis of PCOS status and PCOS related traits.
The per-variant-estimates collected from the contributing studies were meta-analyzed using a fixed-effect, inverse-weighted-variance meta-analysis that employed either GWAMA 47 or METAL 48 . In addition to the overall meta-analysis, we performed metaanalyses for studies with available data for the separate PCOS diagnostic criteria: NIH, Rotterdam 7 and self-report 17 , as well as for the PCOS related traits of HA, OD and PCOM. The meta-analysis of PCOS status was performed using two models; (1) age-adjusted, (2) age and BMI-adjusted, given the high prevalence of obesity in affected women that resulted in cases being significantly heavier than controls in most cohorts ( Table 1) .
We removed any variants that were not present in more than 50% of the effective sample size prior to combining with 23andMe as this was the largest cohort in the meta-analysis, providing approximately 51% of the PCOS cases and 80% of controls.
We also removed any variants only present in one study. The meta-analysis of PCOS related traits was performed adjusting for age and BMI. Identified variants were annotated for insight into their biological function using ANNOVAR 49 to assign refGene gene information, SIFT score 50 , PolyPhen2 scores 51 , CADD scores 52 , GERP scores 53 and SiPhy log odds 54 .
Comparison of PCOS Diagnostic Criteria
Since the Rotterdam diagnostic criteria include the NIH phenotype of OD and HA, the Rotterdam criteria cohorts included a subset of NIH phenotype cases, as indicated in Table 1 . The Rotterdam criteria cohorts containing the NIH phenotype were compared to the NIH criteria cohorts for the analysis of the genetic architecture of the diagnostic criteria. We lacked adequate statistical power to compare the four PCOS phenotypes ( Supplementary Figure 1) or to compare the NIH to the non-NIH Rotterdam phenotypes.
Identifying Associations Between PCOS Loci and PCOS related traits.
In order to understand biology relevant to identified PCOS susceptibility, we assessed the association between index SNPs at each genome-wide-significant locus and the PCOS related traits HA, OD, PCOM as well as the quantitative traits testosterone, LH and FSH levels and ovarian volume. The threshold for significance in this analysis was p<4.5×10 -4 (Bonferroni correction [0.05/(14 independent loci x 8 traits)].
Identifying Shared Risk Loci Between European Ancestry and Han Chinese PCOS
In order to identify shared risk loci between the previously reported GWAS in Han
Chinese PCOS cases and our European ancestry cohort, 13 independent signals (represented by 15 SNPs) at 11 genome-wide significant loci reported by Chen et al. 14 and Shi et al. 15 were investigated for association in our meta-analyses of PCOS and PCOS related traits. The adjusted P-value for this analysis was <0.00048 (Bonferroni correction [0.05/(13 independent signals x 8 traits)]).
Biologic Function of Genes in Associated Loci
Information on the biological function of the nearest gene (or genes, if variants were equidistant from more than one coding transcript and annotated as such by ANNOVAR 49 
Weighted genetic risk score and prediction
One potential use of genetic risk scores is prediction of disease. The ability of genetic risk scores calculated from loci discovered in analysis of the different diagnostic criteria to discriminate cases from alternative criteria was measured. We constructed a weighted genetic risk score based on a meta-analysis excluding the Rotterdam Study subjects. The weighted genetic risk score was divided into quintiles and tested for association with PCOS in the Rotterdam cohort. The middle quintile was used as the reference and the odds for having PCOS based on both Rotterdam or NIH criteria was then calculated.
Additionally, the 23andMe results were used to select independent SNPs with cut-offs of p<5×10 -4 to p<5×10 -8 . The Rotterdam cohort was then used to calculate risk scores and the area-under-the curve (AUC) for both NIH and Rotterdam diagnostic criteria.
Analyses were performed using PLINK v1.9 and SPSS v21 (IBM Corp, Armonk, NY) 57
Linkage Disequilibrium (LD) Score Regression
To assess the level of shared etiology between PCOS and related traits, we performed genetic correlation analysis using LD-score regression 58 . Publicly available genome-wide summary statistics for body mass index (BMI) 59 , childhood obesity 60 , fasting insulin levels (adjusted for BMI) 61 , type 2 diabetes 62 , high-density lipoprotein (HDL) levels 63 , menarche timing 64 , triglyceride levels 63 , coronary artery disease 65 , depression 63 , menopause 17 and male pattern balding 66 were used to estimate the genome-wide genetic correlation with PCOS. The adjusted P-value for this analysis was p<0.0045 after a Bonferroni correction (0.05/11 traits).
Mendelian Randomization
Phenotypes of interest, both where there was evidence of shared genetic architecture and where there was previous evidence for genetic links, were assessed using Mendelian randomization methods. Mendelian randomization differs from LD score regression in that one phenotype is analysed as a potential causal factor for another.
Mendelian randomization was performed using both inverse weighted variance and
Egger's regression methods 67 , with inverse weighted methods being more powerful, but Egger's methods being resistant to directional pleiotropy (where there are a set of SNPs that appear to have an alternative pathway of effect). In addition to the phenotypes implicated by the LD-score regression measures, male pattern balding has a strong biological rationale and was therefore included. The genetic score for childhood obesity substantially overlaps with the score for adult BMI (such that the INSIDE violation -where the effect of SNPs on a confounding factor scales with that on the trait of interest -of Mendelian randomization would likely occur 68 , so only a score for BMI was used, with the proviso that this represents BMI across the whole of the life course after very early infancy. The SNPs for Depression were drawn from the results of a more recent analysis, for which there was not, at time of analysis, publicly available genome-wide data.
Credible Sets
We defined a locus as mapping within 500kb of the lead SNP. For each locus, we first calculated the posterior probability, π Cj , that the jth variant is driving the association, given byc = where the summation is over all retained variants in the locus. In this expression, Λ j is the approximate Bayes' factor 69 for the jth variant, given by
where β j and V j denote the estimated allelic effect (log-OR) and corresponding variance from the meta-analysis. The parameter ω denotes the prior variance in allelic effects, taken here to be 0.04 69 . The 99% credible set 70 for each signal was then constructed by: (i) ranking all variants according to their Bayes' factor, Λ j ; and (ii)
including ranked variants until their cumulative posterior probability of driving the association attained or exceeded 0.99.
SUPPLEMENTARY MATERIALS
SUPPLEMENTARY NOTES
Supplementary Results.
In addition to these 14 significant loci, there was suggestive evidence of a 15th signal, 71 . THADA has been associated with endocrine and metabolic disturbances commonly found in PCOS, such as increased LH, testosterone and LDL levels and T2D 75 . Proposed to modify PCOS risk through metabolic mechanisms 76 . 3. IRF1 (interferon regulatory factor 1): Located at 5q31.1 (Chr5: 131813204-131813204); Belongs to the interferon regulatory transcription factor (IRF) family.
ERBB4 (erb
Activates the transcription of interferons alpha and beta, and genes induced by interferons alpha, beta and gamma (USCS, GeneNetwork, NCBI gene database).
IRF1 displays a functional diversity in the regulation of cellular responses including host response to viral and bacterial infections, inflammation, and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage (UniProtKB). Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells 84 . It has been shown in fathead minnow that IRF1 may function as early molecular switches to control phenotypic changes in ovary tissue architecture and function in response to androgen or antiandrogen exposure 85 . Located at 5q31. (Chr5: 131892616-131980313) ;
RAD50 (RAD50 homolog):
Rad50, a protein involved in DNA double-strand break repair 82 . This protein forms a complex with MRE11 and NBS1. The protein complex binds to DNA and displays numerous enzymatic activities that are required for non-homologous joining of DNA ends, and is important for DNA double-strand break repair 86 , telomere maintenance, and meiotic recombination 87 . Knockout studies of the mouse homolog suggest this gene is essential for cell growth and viability 88 . Located at 8p23.1-p22 (Chr 8: 11623889-11623889 ). GATA4 encodes a zinc-finger transcription factor that recognizes the GATA motif in the promoters of various genes (RefSeq). GATA4 is implicated in regulating granulosa cell differentiation, proliferation and function and is expressed in follicles, embryoid bodies and chorion of women with PCOS 89 . Knockdown of GATA4 and GATA6 impairs folliculogenesis and induces infertility 30, 90 . The loss of GATA4 within the ovary results in impaired granulosa cell proliferation and theca cell recruitment 91 . Knockdown of both genes affects expression of FSH receptor, LH receptor, inhibin α and β 30, 89 . In rats with reproductive and metabolic abnormalities similar to PCOS, GATA4 has been associated with the biosynthesis and metabolism of steroids 92 . It is also proposed to modify PCOS risk through metabolic and inflammatory mechanisms 76 .
GATA4 (GATA binding protein 4):
PLGRKT (Plasminogen receptor, C-terminal lysine transmembrane protein):
Located at 9p24.1. (Chr 9; 5440339-5440839) . PLGRKT encodes a plasminogen receptor involved in regulating macrophage migration and regulates catecholamine release 93 However, the region also includes genes for two hormones that regulate gluconeogenesis (FBP1, FBP2), and for PTCH1, which is a receptor for hedgehog proteins. In mice, the hedgehog signaling has been shown to be important for ovarian follicle development and is also implicated in the proliferation and steroidogenesis of theca cells 96 . This is supported by the association between rs4385527 in C9orf3 and anovulation, HA and polycystic ovarian morphology (PCOM) 73 . This protein is located in the nucleus and is involved in cell cycle progression. The zinc finger protein has a pro-apoptotic and anti-proliferative activity and has been marked as an androgen-responsive gene with anti-proliferative activity in prostate cancer cells 23 . PLZF binds to the GATA4 gene regulatory region and activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2 24 . The loss of PLZF has been related to increased proliferation, invasiveness and motility, and resistance to apoptosis in different cancer cell types 110 .
PLZF is considered a tumor suppressor gene in various cell types and tissues. Upregulated during adipocyte differentiation in vitro 25 . Involved in control of early stages of spermatogenesis 26 , and critical for endometrial stromal cell decidualization 27 .
ERBB3 (erb-b2 receptor tyrosine kinase 3; also known as HER3):
Located at 12q13. A member of the EGFR family of receptor tyrosine kinases (RefSeq). The ERBB3 gene is a potential susceptibility locus for T1D and has also been associated with PCOS 15, 111 . ERBB4 together with ERBB3-binding protein 1 may modulate the protein cascade that leads to differentiation of ovarian somatic cells.
ERBB3 interacts with the YAP protein in the Hippo pathway and is implicated in ovarian cell tumors 112 . The same region also includes RAB5B and a SNP in this region has been associated with response to glycose stimulation 113 82 . The region also includes the testosterone-and estrogen-sensitive GLIPR1, GLIPR1L1 and GLIPR1L2 genes, which encode proteins involved in male germ cell maturation and spermoocyte binding [117] [118] [119] . Proposed to modify PCOS risk through metabolic mechanisms 76 .
TOX3 (TOX high mobility group box family member 3): Located at
16q12.1. This gene regulates Ca2+-dependent neuronal transcription through interaction with the cAMP-response-element-binding protein (CREB) 120 . The protein encoded by this gene contains an HMG-box, indicating that it may be involved in bending and unwinding of DNA and alteration of chromatin structure (RefSeq). The Cterminus of the encoded protein is glutamine-rich due to CAG repeats in the coding sequence. A minor allele of this gene has been implicated in an elevated risk of breast cancer. In normal human tissues, TOX3 is largely expressed in the central nervous system (CNS), in the ileum, and within the brain in the frontal and occipital lobe. TOX3 overexpression induces transcription involving isolated estrogen-responsive elements and estrogen-responsive promoters, and protects neuronal cells from cell death caused by endoplasmic reticulum stress or BAX overexpression 120 . TOX3 has been highlighted as a potential PCOS susceptibility locus before and there is evidence it may modify the hyperandrogenemic aspects of the syndrome 15, 121 . Proposed to modify PCOS risk through inflammatory mechanisms 76 . interacts with the low-density lipoprotein receptor related protein 1 (LRP1), which controls adipogenesis 28 and may additionally mediate ovarian angiogenesis and follicle development 29 . EB1 binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton 82 . It is thought that this protein is involved in suppression of microtubule dynamic instability, regulation of microtubule polymerization and spindle function, and chromosome stability (RefSeq). This gene has been marked as a prognostic marker in chronic lymphocytic leukemia and has been suggested as a biological mechanism in chroinic lymphocytic leukemia -CLL 122 . The Xp22.3 region also includes the gene for glycogenin 2 (GYG2), which is involved in glycogen biosynthesis and blood glucose homeostasis. It has been shown that glycogen biosynthesis pathways are impaired in PCOS 123, 124 .
MAPRE1 (Microtubule
ARSD (arylsulfatase D): Located at
Supplementary note on gene enrichment analysis.
We Functional annotations used in these analyses were transcription factor binding sites (172 transcription factors) 130 and chromatin states in different tissues (n=196) 131 . We investigated whether the 14 PCOS-associated susceptibility variants detected in this study and the variants in LD with them (r 2 >0.6) co-localized with specific functional annotations. The results from gene set analysis did not show results that we found particularly trustworthy, and the methods of MAGENTA have been criticized elsewhere so these are only reported in the supplement. No individual pathway appeared to be significant. GoShifter analyses for identification of enriched functional annotations did not reveal any statistically significant finding (all p-value>0.05).
DEPICT tissue identification approach reinforced the importance of ovarian morphology, with ovarian follicle, ovum, oocytes, ovary, granulosa cells, fallopian tubes and cumulus cells all showing nominally significant p-values (p-value<0.05).
This is alongside the more general enrichment at endocrine cells and adipocytes.
The nominally significant findings for ovaries in the tissue identification analysis suggested the importance of ovarian morphology in PCOS pathogenesis. However, no individual pathway appeared to be significant in gene-set enrichment and gene prioritization analyses. A potential explanation for the lack of significant findings is that these methods are limited by the functional data available for the tissues relevant to PCOS and its related traits, e.g. ovary. In addition, DEPICT and GoShifter analyses were based on the 14 PCOS GWAS meta-analysis susceptibility variants, which may limit the power of these approaches to detect significant enrichments 129 . Supplementary Table 1 : Cohorts contributing polycystic ovary syndrome (PCOS) cases, PCOS phenotypes, laboratory data and controls.
SUPPLEMENTARY DATA
Supplementary Tables:
Supplementary Table 2 : Fine-mapping of PCOS risk loci identified in the metaanalysis to narrow candidate causal variants. Clustering by column (phenotype/trait) demonstrates the large proportion of PCOS loci that are also significantly associated with ovulatory dysfunction (OD) and polycystic ovarian morphology (PCOM).
Supplementary
